pocketful logo
Kopran Ltd logo

Kopran Ltd

NSE: KOPRAN BSE: 524280

₹155.33

(-2.49%)

Wed, 22 Apr 2026, 10:46 am

Kopran Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    737.56

  • Net Profit

    38.55

  • P/B

    1.63

  • Sector P/E

    32.38

  • P/E

    21.94

  • EV/EBITDA

    12.58

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.85

  • ROCE (Industry)

    13.28

  • RONW (Industry)

    12.53

  • ROE

    7.64

  • ROCE

    9.60

  • Debt/Equity

    0.24

  • EPS (TTM)

    3.43

  • Dividend Yield

    1.96

  • Book Value

    103.77

  • Interest Cover

    6.56

Analysis

all

thumbs up icon

Pros

  • Kopran is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Kopran is profitable, therefore cash runway is not a concern.
  • Kopran is profitable, therefore cash runway is not a concern.
  • Debt is well covered by operating cash flow (39.4%, greater than 20% of total debt).
  • Debt is covered by short term assets, assets are 2.4x debt.
thumbs up icon

Cons

  • Unable to evaluate Kopran's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Kopran's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Kopran's level of debt (49%) compared to net worth is high (greater than 40%).
  • High level of physical assets or inventory.
  • The average tenure for the Kopran board of directors is less than 3 years, this suggests a new board.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters44.4244.4244.4244.4244.42
FII0.570.360.600.761.12
DII0.000.000.000.000.00
Public55.0055.2254.9854.8254.45
Government00000

Read More

Technical Analysis

RSI

69.14

MACD

9.38

50 DMA

132.04

200 DMA

151.32

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic162.37138.79123.41115.2199.8391.6368.05
Fibonacci138.79129.78124.21115.21106.20100.6391.63
Camarilla114.52112.36110.20115.21105.88103.72101.56

Pivots Level: Classic

R3

+47.16

162.37

R2

+23.58

138.79

R1

+8.21

123.41

115.21
115.21
Pivot Point
LTP: 161.18

S1

-15.37

99.83

S2

-23.58

91.63

S3

-47.16

68.05

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    151.79

  • 20-EMA

    143.28

  • 30-EMA

    139.00

  • 50-EMA

    136.32

  • 100-EMA

    139.20

  • 200-EMA

    151.87

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
22 Jan 2026board-meetingsQuarterly Results
12 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
04 Aug 2025dividendFinal Dividend - Rs. - 304 Sept 2025
29 Jul 2025agm
15 May 2025dividend₹3.00 Dividend /Share04 Sept 2025
19 Aug 2024agm
02 Aug 2024dividendAnnual General Meeting/Dividend - Rs 3 Per Share03 Sept 2024
16 May 2024dividend₹3.00 Dividend /Share03 Sept 2024
17 Aug 2023agm
07 Aug 2023dividendAnnual General Meeting/Dividend - Rs 3 Per Share08 Sept 2023

Read More

Peer Comparison

Kopran Ltd logo

Kopran Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Lupin Ltd logo

Lupin Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Read More

Kopran Ltd About

Kopran is engaged in the business of manufacturing of Formulation (Finished Dosage Form).

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1958

Headquarters

CEO

Susheel G Somani

Employees

Contact

Website icon

Website

http://www.kopran.com

Email icon

Email

sunil@kopran.com

Phone icon

Phone

91-22-43661111

Location icon

Location

Parijat House 1076, Dr E Moses Road Worli, Mumbai, Maharashtra, 400018

Read More

Kopran Ltd Company History

YearHistory
2005
  • The Company appointed Mr.H.P.Vyas as Company Secretary
  • The Company entered into a Strategic Alliance with Merck Specialities Pvt Ltd
2006
  • The company signed a distribution pact with Mumbai-based Manish Pharma for its complete range of over the counter (OTC) products
2011
  • The company appointed Mr. Abhinav Mathur as a Company Secretary & Compliance Officer
2013
  • Kopran Ltd. launched a new brand SPARKLE in the FMCG category
2018
  • Kopran Research Laboratories Limited, a wholly owned subsidiary of the Company purchased API facility at Panoli, Gujarat

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
HRTI PRIVATE LIMITEDBuy272129154.5830 Dec 2025
HRTI PRIVATE LIMITEDSell256605154.6130 Dec 2025
SILVERLEAF CAPITAL SERVICES PRIVATE LIMITEDSell500612152.1623 Dec 2025
NK SECURITIES RESEARCH PRIVATE LIMITEDSell367990151.523 Dec 2025
NK SECURITIES RESEARCH PRIVATE LIMITEDBuy367990151.3823 Dec 2025
SILVERLEAF CAPITAL SERVICES PRIVATE LIMITEDBuy500612152.0423 Dec 2025
VIRAJ RUSSELL MEHTASell400000179.623 Jun 2025
VANDANA SURENDRA SOMANIBuy317500174.1319 Mar 2025
G CLARIDGE &COMANY LTDSell317500174.1319 Mar 2025
BOFA SECURITIES EUROPE SABuy251971348.6513 Sept 2024

Read More

Kopran Ltd News

Kopran Gets NCLT Nod for Merger Creditor Meetings

NCLT Mumbai directs Kopran Limited to conduct shareholder and creditor meetings for proposed merger with subsidiary Kopran Laboratories Limited under amalgamation scheme.

10 Apr 2026

companies

Kopran Clarifies Price Movement to BSE, Cites Market Forces

Kopran Limited responds to BSE inquiry on price movement, confirming compliance with disclosure requirements and attributing increase to market-driven factors.

10 Apr 2026

companies

Kopran Files Q4FY26 Compliance Certificate

Kopran Limited submits certificate confirming compliance with SEBI Regulation 74(5) for dematerialization processes during quarter ended March 31, 2026.

09 Apr 2026

companies

Kopran Responds to BSE Volume Movement Inquiry

Kopran Limited clarifies to BSE that recent volume increase is market-driven, confirming compliance with all disclosure requirements under SEBI regulations.

08 Apr 2026

companies

Kopran Director Adarsh Somani Resigns Effective March 17

Kopran Limited announces resignation of Non-Executive Non-Independent Director Mr. Adarsh Somani effective March 17, 2026, following family settlement among promoters regarding shareholding and directorship.

17 Mar 2026

companies

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800